Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, has acquired all of the operations of HEKA Elektronik, or HEKA, a privately held biomedical instrumentation and software business with headquarters in Germany.

As a key developer of patch clamp amplifier instrumentation for biomedical research applications, HEKA substantially bolsters Harvard Bioscience’s product portfolio in the electrophysiology market. Included in the acquisition of HEKA are: HEKA Electronik Dr. Schulze GmbH, based in Lambrecht, Germany; HEKA Electronics Incorporated, based in Chester, Nova Scotia, Canada; and HEKA Instruments Incorporated, based in Bellmore, New York.

EC Mergers & Acquisitions acted as exclusive financial advisor to Harvard Bioscience on this transaction.